The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Peripheral Vascular Diseases

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Peripheral Vascular Diseases

 

Psychiatry related information on Peripheral Vascular Diseases

 

High impact information on Peripheral Vascular Diseases

 

Chemical compound and disease context of Peripheral Vascular Diseases

 

Biological context of Peripheral Vascular Diseases

 

Anatomical context of Peripheral Vascular Diseases

 

Gene context of Peripheral Vascular Diseases

  • The cellular mechanism of abnormal lipid transport and metabolism in SCCD is of interest due to its potential involvement in atherosclerosis, and its implications for the pathogenesis of cerebrovascular, coronary and peripheral vascular disease as well as corneal opacification [26].
  • Moreover, 2 wk of BMOV treatment in a rat model of peripheral vascular disease enhanced collateral blood flow similarly to VEGF, and after 4 wk, BMOV was superior to VEGF [27].
  • CONCLUSIONS: These results suggest that IGF-1 may be important in the pathogenesis of peripheral vascular disease by increasing endothelial cell-monocyte adhesion by means of an increase in the expression of ICAM-1 and VCAM-1 [28].
  • The objective of this study was to analyze the relation between circulating immune complexes and C4 null alleles in patients operated on for peripheral vascular disease before the age of 50 [29].
  • The finding of a mutation in NDP in association with peripheral vascular disease may provide valuable insight into the potential role of this gene in cellular processes [30].
 

Analytical, diagnostic and therapeutic context of Peripheral Vascular Diseases

References

  1. Is sex a factor in determining operative risk for aortocoronary bypass graft surgery? Mickleborough, L.L., Takagi, Y., Maruyama, H., Sun, Z., Mohamed, S. Circulation (1995) [Pubmed]
  2. Insulin response to oral glucose in patients with a previous myocardial infarction and in patients with peripheral vascular disease. Hyperinsulinism and its relationships to hypertriglyceridemia and overweight. Sorge, F., Schwartzkopff, W., Neuhaus, G.A. Diabetes (1976) [Pubmed]
  3. Prevalence of complications among second-generation Japanese-American men with diabetes, impaired glucose tolerance, or normal glucose tolerance. Fujimoto, W.Y., Leonetti, D.L., Kinyoun, J.L., Shuman, W.P., Stolov, W.C., Wahl, P.W. Diabetes (1987) [Pubmed]
  4. Renal artery stenosis: a common and important problem in patients with peripheral vascular disease. Missouris, C.G., Buckenham, T., Cappuccio, F.P., MacGregor, G.A. Am. J. Med. (1994) [Pubmed]
  5. Ischemic stroke after surgical procedures: clinical features, neuroimaging, and risk factors. Limburg, M., Wijdicks, E.F., Li, H. Neurology (1998) [Pubmed]
  6. Heparin-induced platelet aggregation in anorexia nervosa and in severe peripheral vascular disease. Mikhailidis, D.P., Barradas, M.A., Jeremy, J.Y., Gracey, L., Wakeling, A., Dandona, P. Eur. J. Clin. Invest. (1985) [Pubmed]
  7. Contra-indications to metformin therapy are largely disregarded. Holstein, A., Nahrwold, D., Hinze, S., Egberts, E.H. Diabet. Med. (1999) [Pubmed]
  8. Physician motivations for nonscientific drug prescribing. Schwartz, R.K., Soumerai, S.B., Avorn, J. Social science & medicine (1982) (1989) [Pubmed]
  9. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. Lerman, A., Edwards, B.S., Hallett, J.W., Heublein, D.M., Sandberg, S.M., Burnett, J.C. N. Engl. J. Med. (1991) [Pubmed]
  10. Synergistic effect of prostaglandin E1 and isosorbide dinitrate in peripheral vascular disease. Sinzinger, H., Fitscha, P., O'Grady, J., Rauscha, F., Rogatti, W., Vane, J.R. Lancet (1990) [Pubmed]
  11. H.D.L. cholesterol in peripheral vascular disease. Zilcher, H., Kaliman, J., Müller, M. Lancet (1979) [Pubmed]
  12. Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease. Kroon, A.A., van Asten, W.N., Stalenhoef, A.F. Ann. Intern. Med. (1996) [Pubmed]
  13. Prostaglandin E-1 and peripheral vascular disease. Kyle, V., Hazleman, B. Lancet (1983) [Pubmed]
  14. Identification of patients at greatest risk for developing major complications at cardiac surgery. Hammermeister, K.E., Burchfiel, C., Johnson, R., Grover, F.L. Circulation (1990) [Pubmed]
  15. Muscle carnitine deficiency in patients with severe peripheral vascular disease. Brevetti, G., Angelini, C., Rosa, M., Carrozzo, R., Perna, S., Corsi, M., Matarazzo, A., Marcialis, A. Circulation (1991) [Pubmed]
  16. Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double-blind, cross-over study. Brevetti, G., Chiariello, M., Ferulano, G., Policicchio, A., Nevola, E., Rossini, A., Attisano, T., Ambrosio, G., Siliprandi, N., Angelini, C. Circulation (1988) [Pubmed]
  17. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Robinson, K., Arheart, K., Refsum, H., Brattström, L., Boers, G., Ueland, P., Rubba, P., Palma-Reis, R., Meleady, R., Daly, L., Witteman, J., Graham, I. Circulation (1998) [Pubmed]
  18. Lipoprotein profile in men with peripheral vascular disease. Role of intermediate density lipoproteins and apoprotein E phenotypes. Sentí, M., Nogués, X., Pedro-Botet, J., Rubiés-Prat, J., Vidal-Barraquer, F. Circulation (1992) [Pubmed]
  19. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation. Stevens, M.A., McCullough, P.A., Tobin, K.J., Speck, J.P., Westveer, D.C., Guido-Allen, D.A., Timmis, G.C., O'Neill, W.W. J. Am. Coll. Cardiol. (1999) [Pubmed]
  20. Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis. Blann, A.D., McCollum, C.N. Thromb. Haemost. (1994) [Pubmed]
  21. Superior maturation and patency of primary brachiocephalic and transposed basilic vein arteriovenous fistulae in patients with diabetes. Hakaim, A.G., Nalbandian, M., Scott, T. J. Vasc. Surg. (1998) [Pubmed]
  22. Severe reversible azotemia from captopril therapy. Report of three cases and review of the literature. Chrysant, S.G., Dunn, M., Marples, D., DeMasters, K. Arch. Intern. Med. (1983) [Pubmed]
  23. Vascular calcification and osteolysis in diabetic neuropathy-is RANK-L the missing link? Jeffcoate, W. Diabetologia (2004) [Pubmed]
  24. The effects of nifedipine on blood flow in peripheral vascular disease of the lower limbs. Morgan, R.H., Psaila, J.V., Lewis, P., Davies, W.T., Woodcock, J.P. Eur. Heart J. (1987) [Pubmed]
  25. Modified LDL decreases the binding of prostaglandin E2, I2, and E1 onto monocytes in patients with peripheral vascular disease. Li, S.R., Yang, Q., Koller, E., Kurtaran, A., Bischof, C., Leimer, M., Rauscha, F., Pidlich, J., Virgolini, I. Arterioscler. Thromb. Vasc. Biol. (1997) [Pubmed]
  26. The gene for schnyder's crystalline corneal dystrophy maps to human chromosome 1p34.1-p36. Shearman, A.M., Hudson, T.J., Andresen, J.M., Wu, X., Sohn, R.L., Haluska, F., Housman, D.E., Weiss, J.S. Hum. Mol. Genet. (1996) [Pubmed]
  27. Tyrosine phosphatase inhibition augments collateral blood flow in a rat model of peripheral vascular disease. Carr, A.N., Davis, M.G., Eby-Wilkens, E., Howard, B.W., Towne, B.A., Dufresne, T.E., Peters, K.G. Am. J. Physiol. Heart Circ. Physiol. (2004) [Pubmed]
  28. Cell adhesion molecules and insulin-like growth factor-1 in vascular disease. Balaram, S.K., Agrawal, D.K., Allen, R.T., Kuszynski, C.A., Edwards, J.D. J. Vasc. Surg. (1997) [Pubmed]
  29. Circulating immune complexes and complement C4 null alleles in patients in patients operated on for premature atherosclerotic peripheral vascular disease. Nityanand, S., Truedsson, L., Mustafa, A., Bergmark, C., Lefvert, A.K. J. Clin. Immunol. (1999) [Pubmed]
  30. Norrie disease gene mutation in a large Costa Rican kindred with a novel phenotype including venous insufficiency. Rehm, H.L., Gutiérrez-Espeleta, G.A., Garcia, R., Jiménez, G., Khetarpal, U., Priest, J.M., Sims, K.B., Keats, B.J., Morton, C.C. Hum. Mutat. (1997) [Pubmed]
  31. The behaviour of various platelet function tests during long-term prostacyclin infusion in patients with peripheral vascular disease. Sinzinger, H., Horsch, A.K., Silberbauer, K. Thromb. Haemost. (1983) [Pubmed]
  32. Left ventricular long axis disturbances as predictors for thallium perfusion defects in patients with known peripheral vascular disease. Henein, M.Y., Anagnostopoulos, C., Das, S.K., O'Sullivan, C., Underwood, S.R., Gibson, D.G. Heart (1998) [Pubmed]
  33. Treatment and long-term follow-up of foot infections in patients with diabetes or ischemia: a randomized, prospective, double-blind comparison of cefoxitin and ceftizoxime. Hughes, C.E., Johnson, C.C., Bamberger, D.M., Reinhardt, J.F., Peterson, L.R., Mulligan, M.E., Gerding, D.N., George, W.L., Finegold, S.M. Clinical therapeutics. (1987) [Pubmed]
  34. Dose-related effect of intravenous L-arginine on muscular blood flow of the calf in patients with peripheral vascular disease: a H215O positron emission tomography study. Schellong, S.M., Böger, R.H., Burchert, W., Bode-Böger, S.M., Galland, A., Frölich, J.C., Hundeshagen, H., Alexander, K. Clin. Sci. (1997) [Pubmed]
  35. The assessment of skin viability using fluorescein angiography prior to amputation. Tanzer, T.L., Horne, J.G. The Journal of bone and joint surgery. American volume. (1982) [Pubmed]
 
WikiGenes - Universities